INHIBITION OF TOXICITY AND CARCINOGENICITY OF N-2-FLUORENYLACETAMIDE BY ACETANILIDE

被引：34

作者：

YAMAMOTO, RS

GLASS, RM

FRANKEL, HH

WEISBURGER, EK

WEISBURGER, JH

机构：

来源：

TOXICOLOGY AND APPLIED PHARMACOLOGY | 1968年 / 13卷 / 01期

关键词：

D O I：

10.1016/0041-008X(68)90139-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：108 / +

页数：1

共 27 条

[1]

BRAUER KF, 1959, MEDIZINISCHE GRUN ED, V2, P467

[2]

BUSCH H, 1967, METHODS CANCER RE ED, V1, P307

[3]

BUUHOIE NP, 1959, MEDIZINISCHE GRUNDLA, V2, P467

[4]

CONNEY AH, 1967, PHARMACOL REV, V19, P317

[5] RETARDATION OF AZO-CARCINOGENESIS BY NON-CARCINOGENIC AZO-COMPOUNDS [J].

CRABTREE, HG .

BRITISH JOURNAL OF CANCER, 1955, 9 (02) :310-319

[6] INHIBITION OF CARCINOGENESIS [J].

FALK, HL ;

KOTIN, P ;

THOMPSON, S .

ARCHIVES OF ENVIRONMENTAL HEALTH, 1964, 9 (02) :169-&

[7]

FIRMINGER H, 1961, J NATL CANCER I, V27, P559

[8]

GLAZKO AJ, 1966, ANTIMICROB AGENTS CH, P655

[9] ALTERATION OF METABOLISM OF CARCINOGEN N-2-FLUORENYLACETAMIDE BY ACETANILIDE [J].

GRANTHAM, PH ;

MOHAN, L ;

YAMAMOTO, RS ;

WEISBURGER, EK ;

WEISBURGER, JH .

TOXICOLOGY AND APPLIED PHARMACOLOGY, 1968, 13 (01) :118-+

[10]

HARRIS RJC, 1961, BIOLOGICAL APPROA ED, P387

← 1 2 3 →